A Phase I Study of Asciminib (ABL001) in Combination with Dasatinib and Prednisone for Untreated BCR-ABL1-Positive ALL in Older Adults
| Image |  |
|---|---|
| Description | scholarly article |
| Author/s |
author: Martha Wadleigh |
| Publication date | November 13, 2019 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |